scispace - formally typeset
A

Anand Anbarasu

Researcher at VIT University

Publications -  124
Citations -  1942

Anand Anbarasu is an academic researcher from VIT University. The author has contributed to research in topics: Medicine & Gene. The author has an hindex of 17, co-authored 102 publications receiving 1305 citations.

Papers
More filters
Journal ArticleDOI

Flavonoid from Carica papaya inhibits NS2B-NS3 protease and prevents Dengue 2 viral assembly.

TL;DR: The flavonoid quercetin with highest binding energy against NS2B-NS3 protease which is evident by the formation of six hydrogen bonds with the amino acid residues at the binding site of the receptor is found.
Journal ArticleDOI

Discerning molecular interactions: A comprehensive review on biomolecular interaction databases and network analysis tools.

TL;DR: The distinctive attribute mentioned in this review is not only to provide an overview of tools and web servers for gene and protein-protein interaction (PPI) network analysis but also to extract useful and meaningful information from the interaction networks.
Journal ArticleDOI

Computational Analysis Reveals the Association of Threonine 118 Methionine Mutation in PMP22 Resulting in CMT-1A.

TL;DR: The T118M mutation in PMP22 gene is associated with Charcot Marie Tooth, type 1A and resulted in the overall increase in the stability of the mutant protein, which shows marked structural variation between the wild type and the mutantprotein structures.
Journal Article

Septicaemic melioidosis in a tertiary care hospital in south India.

TL;DR: Melioidosis is an emerging infection in India and the magnitude of the problem can only be assessed by increasing awareness, both of its existence in the clinical setting and its identification in the laboratory.
Journal ArticleDOI

Molecular docking and molecular dynamics studies on β-lactamases and penicillin binding proteins

TL;DR: It is demonstrated that potential β-lactam antibiotics can efficiently bind to different types of PBPs for circumventing β- lactam resistance and opens avenues for the development of newer antibiotics that can target bacterial pathogens.